Combined 13-valent pneumococcal conjugate and 23-valent pneumococcal polysaccharide vaccine regimens for adults with systemic lupus erythematosus: Does the sequence of pneumococcal vaccination affect immunogenicity responses? A single-center cohort study in Brazil.
Rodrigo Poubel Vieira de RezendeMarise Oliveira-SantosLuís Eduardo Coelho AndradeEvandro Mendes KlumbPublished in: Lupus (2023)
The PCV13-priming PPSV23-boost strategy in adults with SLE induced greater antibody responses for most immunogenicity outcomes than those elicited by the PPSV23/PCV13 strategy.